Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Delhi High Court

    Tag: Delhi high court

    You Searched For "Delhi High Court"
    Bevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademark

    Bevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademark

    Farhat Nasim9 Feb 2020 11:30 AM IST
    New Delhi: In a major setback to drug giant Sun Pharmaceuticals Ltd.'s arm, Sun Pharma Laboratories Ltd., the Delhi high court has recently dismissed...
    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

    Farhat Nasim6 Oct 2019 11:10 AM IST
    New Delhi: In a relief to the pharmaceutical giant in a trademark matter, the Delhi High Court has recently restrained the manufacture or sale of...
    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    Medical Dialogues Bureau30 Sept 2019 5:54 PM IST
    It was submitted that notifying blood monitoring devices, digital thermometers, nebulizers and glucometers as DRUGS will result in a substantial hike...
    Fight for Vildagliptin: Natco goes to court against Novartis

    Fight for Vildagliptin: Natco goes to court against Novartis

    Farhat Nasim7 Sept 2019 4:32 PM IST
    Mumbai: Throwing an indirect challenge at patent holder Novartis, drugmaker Natco Pharma has submitted a fresh application in a Hyderabad court...
    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Farhat Nasim1 Sept 2019 2:33 PM IST
    New Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
    Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

    Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

    Medical Dialogues Bureau21 July 2019 4:30 PM IST
    Justice Prathiba M Singh said considering the evidence and the content of the website of Lee Pharmaceuticals of Lee House being identical, a permanent...
    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

    Farhat Nasim15 July 2019 2:52 PM IST
    New Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
    Delhi High Court directs Centre to provide partial list of OTC drugs to doctors, pharmacists

    Delhi High Court directs Centre to provide partial list of OTC drugs to doctors, pharmacists

    Medical Dialogues Bureau5 July 2019 9:30 AM IST
    "As things stand today, it is not that difficult to provide a list of OTC drugs," the court said, directing that a "partial list" be provided to...
    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Farhat Nasim29 Jun 2019 11:56 AM IST
    The court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
    Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

    Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

    Farhat Nasim13 Jun 2019 3:23 PM IST
    New Delhi: Breaking the alleged cartel of public sector general insurance companies when it comes to mediclaim treatment, the Delhi High court has...
    End of ENDS: CDSCO moves to ban electronic smoking devices by classifying them as DRUGS

    End of ENDS: CDSCO moves to ban electronic smoking devices by classifying them as DRUGS

    Farhat Nasim12 Jun 2019 11:30 AM IST
    Indian drug regulator, the Central Drugs Standard Control Organisation (CDSCO), under the health ministry has proposed that manufacture, sale and...
    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Farhat Nasim11 Jun 2019 3:31 PM IST
    New Delhi: Bringing in a third party, the Delhi High Court has directed Radha Soami Satsang Beas (RSSB) chief Gurinder Singh Dhillon and his family...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok